Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPECT Brain Imaging of Dopamine Transporter in Depression
NCT00655057Phase 3Completed
- Sponsor
- University of Pennsylvania
- Start
- Oct 2005
- Primary completion
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of escitalopram in major depressive disorder (MDD), sponsored by University of Pennsylvania. Started Oct 2005; status: completed.
02
Drugs
escitalopram
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00655057.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00655057.